Telomere length, telomere‐related genes, and breast cancer risk: The breast cancer health disparities study
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Telomeres are involved in maintaining genomic stability. Previous studies have linked both telomere length (TL) and telomere‐related genes with cancer. We evaluated associations between telomere‐related genes, TL, and breast cancer risk in an admixed population of US non‐Hispanic white (1,481 cases, 1,586 controls) and U.S. Hispanic and Mexican women (2,111 cases, 2,597 controls) from the Breast Cancer Health Disparities Study. TL was assessed in 1,500 women based on their genetic ancestry. TL‐related genes assessed were MEN1, MRE11A, RECQL5, TEP1, TERC, TERF2, TERT, TNKS, and TNKS2. Longer TL was associated with increased breast cancer risk [odds ratio (OR) 1.87, 95% confidence interval (CI) 1.38, 2.55], with the highest risk (OR 3.11, 95% CI 1.74, 5.67 p interaction 0.02) among women with high Indigenous American ancestry. Several TL‐related single nucleotide polymorphisms had modest association with breast cancer risk overall, including TEP1 rs93886 (OR 0.82, 95% CI 0.70,0.95); TERF2 rs3785074 (OR 1.13, 95% CI 1.03,1.24); TERT rs4246742 (OR 0.85, 95% CI 0.77,0.93); TERT rs10069690 (OR 1.13, 95% CI 1.03,1.24); TERT rs2242652 (OR 1.51, 95% CI 1.11,2.04); and TNKS rs6990300 (OR 0.89, 95% CI 0.81,0.97). Several differences in association were detected by hormone receptor status of tumors. Most notable were associations with TERT rs2736118 (OR adj 6.18, 95% CI 2.90, 13.19) with estrogen receptor negative/progesterone receptor positive (ER−/PR+) tumors and TERT rs2735940 (OR adj 0.73, 95% CI 0.59, 0.91) with ER−/PR− tumors. These data provide support for an association between TL and TL‐related genes and risk of breast cancer. The association may be modified by hormone receptor status and genetic ancestry. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Self-citationAdjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix
Li, J., & Ji, L. (2005) · Heredity · doi:10.1038/sj.hdy.6800717 · Cited by 1,458
The association of telomere length and cancer: a meta-analysis
Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0005 · Cited by 458 · cited 1×
“Meta-analyses of TL data and cancer further support the inconsistency of data on associations between TL and cancer, although they have summarized that shortened TL in most often associated with increased cancer risk (Ma et al., 2011; Wentzensen et al., 2011).”
ResultLin, J., Epel, E., Cheon, J., Kroenke, C., Sinclair, E., Bigos, M., Wolkowitz, O., Mellon, S., & Blackburn, E. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.09.012 · Cited by 426 · cited 2×
“Telomeres consist of tandem (TTAGGG)n nucleotide repeats that shorten with aging (Lin et al., 2010) and are necessary for the maintenance of chromosome length because DNA polymerase is unable to replicate the 3I ends of chromosomes.”
BackgroundWolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421 · cited 2×
“However, telomerase activity is usually absent in differentiated cells presumably causing telomeres to shorten with age; when TL reaches a critical limit the cell undergoes senescence (Cassidy et al., 2010; Mirabello et al., 2010a,b; Shammas, 2011; Wolkowitz et al., 2011).”
BackgroundTelomerase directly regulates NF-κB-dependent transcription
Ghosh, A., Saginc, G., Leow, S. C., Khattar, E., Shin, E. M., Yan, T. D., Wong, M., Zhang, Z., Li, G., Sung, W.-K., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2621 · Cited by 378 · cited 1×
“However, the associations observed between SNPs and TL may stem from non-telomere related mechanisms (Epel et al., 2004; Wolkowitz et al., 2011; Ghosh et al., 2012).”
BackgroundShortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis
Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K. A., Dunning, A. M., Svenson, U., Roos, G., Hosgood, H. D., Shen, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020466 · Cited by 376 · cited 1×
“Meta-analyses of TL data and cancer further support the inconsistency of data on associations between TL and cancer, although they have summarized that shortened TL in most often associated with increased cancer risk (Ma et al., 2011; Wentzensen et al., 2011).”
ResultThe power of exercise: buffering the effect of chronic stress on telomere length
Puterman, E., Lin, J., Blackburn, E., O'Donovan, A., Adler, N., & Epel, E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010837 · Cited by 339
Telomere length in different tissues of elderly patients
Friedrich, U., Griese, E.-U., Schwab, M., Fritz, P., Thon, K.-P., & Klotz, U. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00173-1 · Cited by 325 · cited 1×
“Studies have shown that an individual’s TL is tissue independent and that TL in blood is a surrogate for relative TL in other tissues (Friedrich et al., 2000).”
BackgroundJones, A. M., Beggs, A. D., Carvajal-Carmona, L., Farrington, S., Tenesa, A., Walker, M., Howarth, K., Ballereau, S., Hodgson, S. V., Zauber, A., et al. (2012) · Gut · doi:10.1136/gut.2011.239772 · Cited by 113 · cited 2×
“…is responsible for the maintenance of TL. Telomerase activity is usually absent from differentiated cells; however, it has been previously observed in multiple types of cancer cells, including breast cancer (Bautista et al., 2007; Hofer et al., 2011; Mohajeri et al., 2011; Jones et al., 2012).”
BackgroundHoen, P. W., de Jonge, P., Na, B. Y., Farzaneh-Far, R., Epel, E., Lin, J., Blackburn, E., & Whooley, M. A. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31821b1f6e · Cited by 106 · cited 2×
“…(TL) has been linked to a number of diseases, including cardiovascular diseases, diabetes, osteosarcoma, and multiple types of cancer (Mirabello et al., 2009; Njajou et al., 2009; Mirabello et al., 2010a,b; Pooley et al., 2010; Hoen et al., 2011; Mirabello et al., 2011; O’Donovan et al., 2011).”
Background
Cited by
The Telomeres Mendelian Randomization Collaboration, Haycock, P. C., Burgess, S., Nounu, A., Zheng, J., Okoli, G. N., Bowden, J., Wade, K. H., Timpson, N. J., Evans, D. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5945 · Cited by 513
Gender and telomere length: Systematic review and meta-analysis
Gardner, M., Bann, D., Wiley, L., Cooper, R., Hardy, R., Nitsch, D., Martin-Ruiz, C., Shiels, P., Sayer, A. A., Barbieri, M., et al. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.004 · Cited by 513
Telomere Biology and Human Phenotype
Turner, K., Vasu, V., & Griffin, D. (2019) · Cells · doi:10.3390/cells8010073 · Cited by 385
The association between telomere length and cancer risk in population studies
Zhu, X., Han, W., Xue, W., Zou, Y., Xie, C., Du, J., & Jin, G. (2016) · Scientific Reports · doi:10.1038/srep22243 · Cited by 146
Machiela, M. J., Hsiung, C. A., Shu, X., Seow, W. J., Wang, Z., Matsuo, K., Hong, Y., Seow, A., Wu, C., Hosgood, H. D., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29393 · Cited by 90
Self-citation
Metadata
- Authors
- Pellatt, A. J., Wolff, R. K., Torres‐Mejia, G., John, E. M., Herrick, J. S., Lundgreen, A., Baumgartner, K. B., Giuliano, A. R., Hines, L. M., Fejerman, L., Cawthon, R., & Slattery, M. L.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2013-04-30
- Volume
- 52
- Issue
- 7
- Pages
- 595-609
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W1897447385
- Cited by
- 102
- References
- 11
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.